Jan‐Inge Henter

36.4k total citations · 9 hit papers
221 papers, 19.5k citations indexed

About

Jan‐Inge Henter is a scholar working on Hematology, Immunology and Infectious Diseases. According to data from OpenAlex, Jan‐Inge Henter has authored 221 papers receiving a total of 19.5k indexed citations (citations by other indexed papers that have themselves been cited), including 108 papers in Hematology, 108 papers in Immunology and 82 papers in Infectious Diseases. Recurrent topics in Jan‐Inge Henter's work include Autoimmune and Inflammatory Disorders Research (94 papers), Parvovirus B19 Infection Studies (77 papers) and Immune Cell Function and Interaction (60 papers). Jan‐Inge Henter is often cited by papers focused on Autoimmune and Inflammatory Disorders Research (94 papers), Parvovirus B19 Infection Studies (77 papers) and Immune Cell Function and Interaction (60 papers). Jan‐Inge Henter collaborates with scholars based in Sweden, United States and Germany. Jan‐Inge Henter's co-authors include Göran Elinder, Gritta Janka, Maurizio Aricò, Shinsaku Imashuku, AnnaCarin Horne, Stephan Ladisch, Alexandra H. Filipovich, David Webb, Kenneth L. McClain and Jacek Winiarski and has published in prestigious journals such as Science, New England Journal of Medicine and Proceedings of the National Academy of Sciences.

In The Last Decade

Jan‐Inge Henter

219 papers receiving 19.0k citations

Hit Papers

HLH‐2004: Diagnostic and therapeutic guidelines f... 1991 2026 2002 2014 2006 1999 2002 1991 2019 1000 2.0k 3.0k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. HLH‐2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis
    2006 3.4k citations Jan‐Inge Henter, AnnaCarin Horne et al. Pediatric Blood & Cancer profile →
  2. Perforin Gene Defects in Familial Hemophagocytic Lymphohistiocytosis
    1999 904 citations Jan‐Inge Henter et al. profile →
  3. Treatment of hemophagocytic lymphohistiocytosis with HLH-94 immunochemotherapy and bone marrow transplantation
    2002 629 citations Jan‐Inge Henter Blood profile →
  4. Diagnostic guidelines for hemophagocytic lymphohistiocytosis. The FHL Study Group of the Histiocyte Society.
    1991 617 citations Jan‐Inge Henter et al. PubMed profile →
  5. Recommendations for the management of hemophagocytic lymphohistiocytosis in adults
    2019 598 citations Paul La Rosée, AnnaCarin Horne et al. Blood profile →
  6. Contemporary classification of histiocytic disorders
    1997 597 citations Maurizio Aricò, Jan‐Inge Henter et al. profile →
  7. Chemoimmunotherapy for hemophagocytic lymphohistiocytosis: long-term results of the HLH-94 treatment protocol
    2011 443 citations AnnaCarin Horne, Maurizio Aricò et al. Blood profile →
  8. Confirmed efficacy of etoposide and dexamethasone in HLH treatment: long-term results of the cooperative HLH-2004 study
    2017 392 citations AnnaCarin Horne, Maurizio Aricò et al. Blood profile →
  9. Hemophagocytic Lymphohistiocytosis
    2025 16 citations Jan‐Inge Henter profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jan‐Inge Henter Sweden 66 11.9k 9.5k 8.3k 3.1k 2.3k 221 19.5k
Maurizio Aricò Italy 59 8.5k 0.7× 6.0k 0.6× 5.8k 0.7× 3.6k 1.1× 2.5k 1.1× 315 16.5k
Alexandra H. Filipovich United States 63 11.9k 1.0× 9.3k 1.0× 5.5k 0.7× 664 0.2× 1.8k 0.8× 165 16.3k
Helmut Gadner Austria 73 6.5k 0.5× 2.9k 0.3× 2.9k 0.3× 3.4k 1.1× 3.2k 1.4× 408 20.4k
Fabio Ciceri Italy 59 5.0k 0.4× 4.0k 0.4× 2.3k 0.3× 350 0.1× 643 0.3× 493 15.6k
Taco W. Kuijpers Netherlands 71 2.6k 0.2× 8.9k 0.9× 2.3k 0.3× 1.1k 0.4× 2.1k 0.9× 478 17.8k
Jacek Winiarski Sweden 39 5.0k 0.4× 3.2k 0.3× 2.4k 0.3× 348 0.1× 712 0.3× 147 8.1k
Susan F. Leitman United States 58 5.2k 0.4× 7.1k 0.7× 664 0.1× 728 0.2× 1.1k 0.5× 225 16.1k
Kim E. Nichols United States 58 3.6k 0.3× 6.7k 0.7× 1.9k 0.2× 449 0.1× 672 0.3× 221 12.6k
Michael B. Jordan United States 44 5.1k 0.4× 5.4k 0.6× 3.1k 0.4× 290 0.1× 562 0.2× 160 7.9k
Jean Sibilia France 70 2.7k 0.2× 4.1k 0.4× 835 0.1× 2.1k 0.7× 2.0k 0.9× 460 16.8k

Countries citing papers authored by Jan‐Inge Henter

Since Specialization
Citations

This map shows the geographic impact of Jan‐Inge Henter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jan‐Inge Henter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jan‐Inge Henter more than expected).

Fields of papers citing papers by Jan‐Inge Henter

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jan‐Inge Henter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jan‐Inge Henter. The network helps show where Jan‐Inge Henter may publish in the future.

Co-authorship network of co-authors of Jan‐Inge Henter

This figure shows the co-authorship network connecting the top 25 collaborators of Jan‐Inge Henter. A scholar is included among the top collaborators of Jan‐Inge Henter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jan‐Inge Henter. Jan‐Inge Henter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gavhed, Desirée, et al.. (2025). Quality of life, fatigue, depression, attention deficits, and pain after childhood Langerhans cell histiocytosis. PubMed. 2(3). 100098–100098. 1 indexed citations
2.
3.
Henter, Jan‐Inge, Elena Sieni, Ida Hed Myrberg, et al.. (2024). Diagnostic guidelines for familial hemophagocytic lymphohistiocytosis revisited. Blood. 144(22). 2308–2318. 21 indexed citations
4.
Hagey, Daniel W., Egle Kvedaraite, Mira Akber, et al.. (2023). Myeloid cells from Langerhans cell histiocytosis patients exhibit increased vesicle trafficking and an altered secretome capable of activating NK cells. Haematologica. 108(9). 2422–2434. 3 indexed citations
5.
Greenwood, Tatiana von Bahr, Martin Jädersten, Egle Kvedaraite, et al.. (2022). Screening for neurodegeneration in Langerhans cell histiocytosis with neurofilament light in plasma. British Journal of Haematology. 198(4). 721–728. 11 indexed citations
6.
Xu, Xiaojun, Zebin Luo, Hua Song, et al.. (2022). Simple Evaluation of Clinical Situation and Subtypes of Pediatric Hemophagocytic Lymphohistiocytosis by Cytokine Patterns. Frontiers in Immunology. 13. 850443–850443. 13 indexed citations
7.
Khandagale, Avinash, Miriam Entesarian, Daniel Nilsson, et al.. (2020). Severe congenital neutropenia‐associated JAGN1 mutations unleash a calpain‐dependent cell death programme in myeloid cells. British Journal of Haematology. 192(1). 200–211. 11 indexed citations
8.
Kvedaraite, Egle, Magda Lourda, Hongya Han, et al.. (2020). Patients with both Langerhans cell histiocytosis and Crohn’s disease highlight a common role of interleukin‐23. Acta Paediatrica. 110(4). 1315–1321. 4 indexed citations
9.
Rosée, Paul La, AnnaCarin Horne, Melissa Hines, et al.. (2019). Recommendations for the management of hemophagocytic lymphohistiocytosis in adults. Blood. 133(23). 2465–2477. 598 indexed citations breakdown →
10.
Ehl, Stephan, Itziar Astigarraga, Tatiana von Bahr Greenwood, et al.. (2018). Recommendations for the Use of Etoposide-Based Therapy and Bone Marrow Transplantation for the Treatment of HLH: Consensus Statements by the HLH Steering Committee of the Histiocyte Society. The Journal of Allergy and Clinical Immunology In Practice. 6(5). 1508–1517. 118 indexed citations
11.
Donadieu, Jean, Frédéric Bernard, Max M. van Noesel, et al.. (2015). Cladribine and cytarabine in refractory multisystem Langerhans cell histiocytosis: results of an international phase 2 study. Blood. 126(12). 1415–1423. 90 indexed citations
12.
Kvedaraite, Egle, Magda Lourda, Maja Ideström, et al.. (2015). Tissue-infiltrating neutrophils represent the main source of IL-23 in the colon of patients with IBD. Gut. 65(10). 1632–1641. 89 indexed citations
13.
Maisse, Carine, Alexandre Bélot, M. Mazzorana, et al.. (2013). Chemoresistance of Human Monocyte-Derived Dendritic Cells Is Regulated by IL-17A. PLoS ONE. 8(2). e56865–e56865. 27 indexed citations
14.
Wang, Xiangling, Xiaoli Feng, Na Shao, et al.. (2013). Bortezomib and IL-12 produce synergetic anti-multiple myeloma effects with reduced toxicity to natural killer cells. Anti-Cancer Drugs. 25(3). 282–288. 11 indexed citations
15.
Ma, Jinxia, André Ortlieb Guerreiro‐Cacais, Eva Rudd, et al.. (2011). Syntaxin 11 marks a distinct intracellular compartment recruited to the immunological synapse of NK cells to colocalize with cytotoxic granules. Journal of Cellular and Molecular Medicine. 16(1). 129–141. 25 indexed citations
16.
Ottosson, Anders, Chunyan Ji, Xiaoli Feng, et al.. (2009). Proteasome inhibition induces apoptosis in primary human natural killer cells and suppresses NKp46-mediated cytotoxicity. Haematologica. 94(4). 470–478. 32 indexed citations
17.
Carlsson, Göran, Daniel Garwicz, Magnus Nordenskjöld, et al.. (2006). [Kostmann's syndrome largely elucidated--by Swedish research. 50 years since Rolf Kostmann's pioneering work on severe congenital neutropenia].. PubMed. 103(50-52). 4022–7. 1 indexed citations
18.
Henter, Jan‐Inge, AnnaCarin Horne, Maurizio Aricò, et al.. (2006). HLH‐2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatric Blood & Cancer. 48(2). 124–131. 3420 indexed citations breakdown →
19.
Mosskin, Mikael, et al.. (2002). Brain 18-FDG PET scan in central nervous system langerhans cell histiocytosis. The Journal of Pediatrics. 141(3). 435–440. 21 indexed citations
20.
Bernstrand, Cecilia, et al.. (1996). Intralesional steroids in Langerhans cell histiocytosis of bone. Acta Paediatrica. 85(4). 502–504. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Maurizio Aricò Breakdown of academic impact, for papers by Alexandra H. Filipovich Breakdown of academic impact, for papers by Helmut Gadner Breakdown of academic impact, for papers by Fabio Ciceri Breakdown of academic impact, for papers by Taco W. Kuijpers Breakdown of academic impact, for papers by Jacek Winiarski Breakdown of academic impact, for papers by Susan F. Leitman Breakdown of academic impact, for papers by Kim E. Nichols Breakdown of academic impact, for papers by Michael B. Jordan Breakdown of academic impact, for papers by Jean Sibilia
Rankless by CCL
2026